Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms
about
Matrikine and matricellular regulators of EGF receptor signaling on cancer cell migration and invasionInsidious changes in stromal matrix fuel cancer progressionExtracellular matrix macromolecules: potential tools and targets in cancer gene therapyThe wound healing, chronic fibrosis, and cancer progression triadTenascin-C: Form versus functionIntegrated ligand-receptor bioinformatic and in vitro functional analysis identifies active TGFA/EGFR signaling loop in papillary thyroid carcinomasImproved efficacy and reduced toxicity of doxorubicin encapsulated in sulfatide-containing nanoliposome in a glioma modelBi-directional signaling: extracellular matrix and integrin regulation of breast tumor progressionThe actin associated protein palladin in smooth muscle and in the development of diseases of the cardiovasculature and in cancer.Histone demethylase RBP2 is critical for breast cancer progression and metastasis.14-3-3Tau regulates Beclin 1 and is required for autophagy.Tenascin-C enhances pancreatic cancer cell growth and motility and affects cell adhesion through activation of the integrin pathwayMammary gland morphological and gene expression changes underlying pregnancy protection of breast cancer tumorigenesisCharacterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells.Increased invasiveness and aggressiveness in breast epithelia with cytoplasmic p63 expression.Association of invasion-promoting tenascin-C additional domains with breast cancers in young women.Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cellsRat mammary extracellular matrix composition and response to ibuprofen treatment during postpartum involution by differential GeLC-MS/MS analysis.Tenascin-C is expressed by human glioma in vivo and shows a strong association with tumor blood vessels.Targeting tumor cell motility to prevent metastasis.Advances in tenascin-C biology.Annexin A2 promotes glioma cell invasion and tumor progressionTenascin C in metastasis: A view from the invasive frontTenascin-C Signaling in melanomaAn "elite hacker": breast tumors exploit the normal microenvironment program to instruct their progression and biological diversity.Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro.Reproductive history and breast cancer risk.Symptomatic cardiac metastases of breast cancer 27 years after mastectomy: a case report with literature review--pathophysiology of molecular mechanisms and metastatic pathways, clinical aspects, diagnostic procedures and treatment modalities.A migration signature and plasma biomarker panel for pancreatic adenocarcinoma.Genomic profiling in locally advanced and inflammatory breast cancer and its link to DCE-MRI and overall survival.Tenascin-C serum levels and its prognostic power in non-small cell lung cancer.How do tenascins influence the birth and life of a malignant cell?Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells.High expression of intratumoral stromal proteins is associated with chemotherapy resistance in breast cancer.Epithelial and mesenchymal phenotypic switchings modulate cell motility in metastasisJekyll and Hyde: the role of the microenvironment on the progression of cancer.Stromal biomarkers in breast cancer development and progression.Latent cytokines for targeted therapy of inflammatory disorders.Role of tenascins in the ECM of gliomas.Tenascin-C and carcinoma cell invasion in oral and urinary bladder cancer.
P2860
Q26824518-B1BE3EAF-CCBE-4A1B-AD79-686540439F26Q26851261-A8E07ED3-5F1B-4186-A548-779CA0D5A004Q26996081-8D9BA8A6-8174-4038-ADDC-0356754EB8FCQ27014616-AB3A7268-0D22-401E-B1BC-100C0DFB060AQ27023815-EF7DA8DA-6CC4-4252-8624-2B3486A88DFAQ28475549-6C93012F-F860-4E39-8828-00253709AB16Q28541327-3F02D79C-7C1D-4B03-A614-7D95D115364CQ28822348-3FA18AE4-BA5D-49F7-BA13-312D73DA8390Q30425751-8B19C50E-0AC3-4D0A-9BF8-BF543D379FFCQ33582497-561790A0-1720-41DD-AD8C-53120012CF7EQ33818362-64745EE8-163F-4D0B-B478-E659FD57FF82Q33957943-EBE6CA51-00C4-46E1-87D6-27E84BA70AA8Q33976295-D3303D78-F1E9-4F07-A780-B6E5ADBA6742Q34043793-8B679155-1596-4716-82B8-83D4FCDB0DDAQ34061980-B9C7182E-20FB-484D-A4BE-0931DA45DA8DQ34173505-3118973B-C35E-4209-A593-F73477AB3EC4Q34756114-473747C7-870A-413F-8108-30216F343A6AQ34939050-B9054925-9A98-44DA-B1C5-2BE5FBEC4ED0Q34959853-789BAAF8-774B-42BC-A164-38A8CBB52DFFQ35095152-F984D01A-1D13-4C82-A62A-AEA33DA40EACQ35214557-A9B7629A-C4EB-479B-BA96-385FC129061BQ35448499-F418DEA4-78A0-4913-9C79-63624E9C1900Q35577928-A8A6717B-4829-40A0-A8EA-671D9052148DQ35577952-99F2E0CA-6A46-4C03-8C57-E8870C5016BCQ36187733-FA612552-668A-4DD0-BFDA-7F28A21656B0Q36230697-580FA0C7-0989-44EE-A839-BAD3C7484981Q36342182-0670B4A4-19F4-4610-A3FD-0D41EA9F829AQ36581353-A0B0F67A-D598-4F48-BE36-A20A331DBB28Q36792047-DFD81E9B-7816-4FE0-8BC3-7B8F1DF308D5Q37114252-BAD3E74F-8C9A-4CC8-A099-B4A56B97DE47Q37190491-2FD20216-168E-4A53-ABA3-FF9C58FDFBE8Q37295200-40CB90FF-85B9-4E93-B662-B6C8BEB24C91Q37593533-300625CA-3FDD-4DD3-AF6F-2A9EF332E450Q37688210-98BC224C-92F5-487C-9B06-F708DC6C5CC0Q37730957-4454F5FE-E55D-469D-B883-4DE660388435Q37815128-1EDCF957-44F9-4C6C-A267-D39DDF866B22Q38017601-0F7A57D3-D86E-40B5-A141-1B491363B0FEQ38167818-4838F4F2-C672-425A-89E7-2861B4024017Q38361238-DE65E897-661F-480C-A3D6-E293073D84DEQ38385221-4A8FF352-9126-46C3-8A89-987DD97E435B
P2860
Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumour-associated tenascin-C i ...... ent and independent mechanisms
@en
Tumour-associated tenascin-C i ...... nt and independent mechanisms.
@nl
type
label
Tumour-associated tenascin-C i ...... ent and independent mechanisms
@en
Tumour-associated tenascin-C i ...... nt and independent mechanisms.
@nl
prefLabel
Tumour-associated tenascin-C i ...... ent and independent mechanisms
@en
Tumour-associated tenascin-C i ...... nt and independent mechanisms.
@nl
P2093
P2860
P50
P356
P1476
Tumour-associated tenascin-C i ...... ent and independent mechanisms
@en
P2093
Caroline J Pennington
Deborah L Holliday
J Howard Pringle
J Louise Jones
Rachael A Hancox
Rosemary A Walker
P2860
P2888
P356
10.1186/BCR2251
P577
2009-04-30T00:00:00Z
P5875
P6179
1018374321